CCR4 and neoplasm: Thus, targeted therapy against CCR4 may be an attractive treatment option for these malignancies, not only to directly kill the CCR4+ tumor cells, but also to overcome the suppressive effect of CCR4+ Tregs on the host anti-tumor immune response.